Evidence map›Paper›PMID 36980270›Full record

ArticleCells2023

Carmen Martínez-Fernández, Sweta Jha, Elisabet Aliagas, Carina I Holmberg, Ernest Nadal, Julián Cerón

Open access · goldFull text read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Comprehensive analysis reveals the prognostic and immunological role of PSMD13 in hepatocellular carcinoma.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Carmen Martínez-FernándezModeling Human Diseases in C. elegans Group, Genes, Diseases, and Therapies Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0003-1544-4387
Sweta JhaMedicum, Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.
Elisabet AliagasDepartment of Medical Oncology, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Carina I HolmbergMedicum, Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.ORCID 0000-0001-9645-2009
Ernest NadalDepartment of Medical Oncology, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0002-9674-5554
Julián CerónModeling Human Diseases in C. elegans Group, Genes, Diseases, and Therapies Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Institut d'Investigació Biomédica de Bellvitge · ESUniversity of Helsinki · FIInstitut Català d'Oncologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The deubiquitinase BAP1 (BRCA1-associated protein 1) is associated with

Indexed as

MesotheliomaMesothelioma, MalignantProteasome Endopeptidase ComplexUbiquitin ThiolesteraseAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsDisease Models, AnimalHumansMutationSynthetic Lethal MutationsTumor Suppressor Proteins26S proteasome non-ATPase regulatory subunit 13BAP1 protein, humanCaenorhabditis elegans ProteinsProteasome Endopeptidase ComplexTumor Suppressor Proteinsubh-4 protein, C elegansUbiquitin ThiolesteraseBAP1BortezomibC. elegansCRISPR-CasMalignant Pleural MesotheliomaproteasomePSMD13rpn-9ubh-4

Identifiers

PMID36980270
PMCPMC10047281
OpenAlexW4327951273

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read38
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.